Leading the Change Maximizing Payment Models Melinda S. Hancock, FHFMA, CPA Partner DHG Healthcare 2014-15 Chair Elect, HFMA HFMA Lead #LikeAGirl November 14, 2014 "If your actions inspire others to dream more, learn more, do more, and become more, you are a leader.” – John Quincy Adams ACA Gains through 2019 Amounts in Billions Source:CBO and Joint Committee on Taxation, 2010 Projection Revenue Industry Tipping Point Time • • • • How do local market conditions impact timing considerations? Can market-changing events create an urgent paradigm shift? What is my step-change business model risk? Do I have the financial tools to adequately analyze relevant states? 4 Payment Modelof & Increasing Acceptance Hierarchy Risk andRisk Payment Models 5 Alignment of Strategy and Metrics Questions to Ask • How many metrics am I tracking? • How many metrics are duplicated? Do they have the same numerator and denominator? Source? • Are they aligned with our results and strategic goals? • What contracts are coming up for renewal that should have new metrics or should be at risk (mgd care, medical directorships, PMAs, etc.) • What are we focused on? Reform Timeline Value Based Purchasing VBP Shifting of Domain Weights FY 2013 FY 2014 • Core Measures • Patient Experience FY 2015 FY 2016 • Outcomes • Efficiency (MSPB) New NQS Based Domains for FY 2017 Clinical Care Process = 5% HCAHPS = 25% Clinical Care Outcomes = 25% Safety = 20% MSPB = 25% 10 VBP – FY13 Domain Weights Performance Period: July 1, 2011 – March 31, 2012 Reimbursement Period: October 1, 2012 – September 30, 2013 Core Measures = 70% VBP – FY14 Domain Weights Performance Period: April 1, 2012 – December 31, 2012 Reimbursement Period: October 1, 2013 – September 30, 2014 Outcomes = 25% Core Measures = 45% VBP – FY15 Domain Weights Performance Period: January 1, 2013 – December 31, 2013 Reimbursement Period: October 1, 2014 – September 30, 2015 HCAHPS = 30% Outcomes = 30% Core Measures = 20% MSPB = 20% One Measure!! VBP – FY16 Domain Weights Performance Period: January 1, 2014 – December 31, 2014 Reimbursement Period: October 1, 2015 – September 30, 2016 Core Measures = 10% HCAHPS = 25% MSPB = 25% Outcomes = 40% VBP – FY16 Domain Weights Performance Period: January 1, 2014 – December 31, 2014 Reimbursement Period: October 1, 2015 – September 30, 2016 Clinical Care - Process = 5% HCAHPS = 25% Clinical Care Outcomes = 25% Safety = 20% MSPB = 25% 15 Value Based Purchasing • Outcomes = Income • Mandatory Pay for Performance Program – 3,500 hospitals are included in this program across the country • Reimbursement Determine Two Ways: – Achievement How we compare to National Top Decile (350 Hospitals) – Improvement How we measure against ourselves Did we do better than a previously measured baseline period Value Based Purchasing • • Percent of Medicare Reimbursement at Risk • FY 2013 – 1.00% • FY 2014 – 1.25% • FY 2015 – 1.50% • FY 2016 – 1.75% • FY 2017 – 2.00% • FY 2018 – 2.00% • FY 2019 – 2.00% FY 20xx – refers to the Federal Fiscal Year (Oct. 1 – Sep. 30) when DRG payments will be affected VBP FY 2016 – New Measures • Patient Experience – No Change – Same HCAHPS Measures • Core Measures – 5 Dropped; 1 New • Outcomes – 3 New Measures • Efficiency – No Change VBP – FY 2016 – Patient Experience • HCAHPS – Hospital Consumer Assessment of Healthcare Providers Survey – An engagement survey CMS has mandated each hospital give to every discharged inpatient – Consists of 27 questions that lead to the 8 categories assessed for VBP – Patients score each question on scale of 4 – For answers to count, patients must give hospitals a score of 4 or “Always” VBP FY 2016 – Patient Experience • Communication with Nurses • Communication with Doctors • Responsiveness of Hospital Staff • Pain Management • Communication about Medicines • Cleanliness and Quietness of Hospital • Discharge Information • Overall Rating of Hospital VBP FY 2015 – Core Measures • • • • • • AMI-7a AMI-8a HF-1 PN-3b PN-6 SCIP-Inf-1 • • • • • • SCIP-Inf-2 SCIP-Inf-3 SCIP-Inf-4 SCIP-Inf-9 SCIP-Card-2 SCIP-VTE-2 VBP FY 2016 – Core Measures • AMI-7a • SCIP-Inf-9 • PN-6 • SCIP-Card-2 • SCIP-Inf-2 • SCIP-VTE-2 • SCIP-Inf-3 • IMM-2 Note: IMM-2 Performance Period is only 6 MONTHS (Two 3 Month Periods)January 1, 2014 – March 31, 2014 AND October 1, 2014 – December 31, 2014 VBP FY 2016 – Core Measures Measure ID Benchmark AMI-7a 100% IMM-2 98.875% PN-6 100% SCIP-Inf-2 100% SCIP-Inf-3 100% SCIP-Inf-9 100% SCIP-Card-2 100% SCIP-VTE-2 100% VBP FY 2016 – Core Measures • AMI-7a • SCIP-Inf-9 • PN-6 • SCIP-Card-2 • SCIP-Inf-2 • SCIP-VTE-2 • SCIP-Inf-3 • IMM-2 VBP FY 2017 – Clinical Care: Process • AMI-7a • IMM-2 • PC-01 PC-01 = Elective Delivery Prior to 39 Completed Weeks Gestation VBP FY 2015 – Outcomes • 30 Day Mortality – AMI • 30 Day Mortality – HF • 30 Day Mortality – PN • AHRQ – PSI-90 • CLABSI VBP FY 2016 – Outcomes • 30 Day Mortality – AMI • 30 Day Mortality – HF • 30 Day Mortality – PN • AHRQ – PSI-90 • CLABSI • CAUTI • SSI – Colon • SSI – Abdominal Hysterectomy VBP FY 2016 – Outcomes Measure ID Benchmark CAUTI 0.000 CLABSI 0.000 Surgical Site Infection Colon 0.000 Abdominal Hysterectomy 0.000 VBP FY 2016 – Outcomes Outcomes • 30 Day Mortality – AMI • 30 Day Mortality – HF • 30 Day Mortality – PN • AHRQ – PSI-90 • CLABSI • CAUTI • SSI-Colon • SSI-Abdominal Hyster. VBP FY 2017 – Clinical Care and Safety Clinical Care- Outcomes Safety • 30 Day Mortality – AMI • 30 Day Mortality – HF • 30 Day Mortality – PN • AHRQ – PSI-90 • CLABSI • CAUTI • SSI-Colon • SSI-Abdominal Hyster. • MRSA • C. Diff Reform Timeline Outcomes – 30 Day Mortality • • Currently in 3 Performance Periods – FY 2016 ended June 30, 2014 – FY 2019 began July 1, 2014 30 Day Mortality Measures – Assess deaths: AMI, HF, and PN that occur within 30 days after admission; which, depending on the length of stay, may occur postdischarge…. CMS 30 Day Risk-Standardized Mortality Rate Calculation = Facility Predicted Deaths X Facility Expected Deaths Measure (AMI, HF, PN) National Crude Rate VBP FY 2016 - Efficiency Medicare Spend Per Beneficiary (MSPB) • Captures total Medicare Spending Per Beneficiary relative to a hospital stay, bundling hospital sources (Part A) with post acute care (Part B) – Bundles the cost of care delivered to a beneficiary for an episode across the continuum of care: 3 Days Prior Hospital Inpatient Stay 30 Days post Discharge VBP: MSPB Sample US VBP: MSPB 36 • PROPOSED MSPB Measures Additional Efficiency Measures proposed to be added Medical Surgical Kidney/Urinary Tract Infection Hip replacement/revision Cellulitis Knee replacement/revision Gastrointestinal hemorrhage Lumbar spine fusion/refusion • Risk Adjusted similarly to MSPB • Proposed to facilitate alignment with the Physician Value Based Payment • Modifier program Includes Part A and B and 3 days prior to admission and 30 days post discharge SOURCE: May 1, 2014 Federal Register 37 CGH System VBP FY'13 FY'15 TOTAL PERFORMANCE Earned Back Unearned Available $$ $4,925,357 $288,853 $6,187,541 $540,406 $11,112,898 $829,259 $4,925,357 % Earned 34.83% 44.32% Breakeven Point: $5,301,360 Breakeven Point: $451,333 $288,853 $0 $0 $829,259 $11,112,898 Chesapeake OverallGeneral Performance Performance System was penalized $376,003 in FY’15 VBP Program • Must acknowledge the amount UNEARNED • Of the programs dollars made available: – System did not capitalize on $6,187,541 Facility Earned Back $381,643 Core Measures Unearned Measure Value $218,077 $599,720 % Earned 63.64% Breakeven Point: $232,525 Facility $539,763 $599,720 Earned Back $278,896 $278,896 HCAHPS Unearned Measure Value $620,704 $899,600 % Earned 60.00% Breakeven Point: $348,788 $381,643 $0 Facility Earned Back $539,763 Outcomes Unearned Measure Value $359,837 $899,600 % Earned 31.00% $0 Facility Earned Back $59,974 Breakeven Point: $348,788 $899,600 Efficiency Unearned Measure Value $539,746 $599,720 % Earned 10.00% Breakeven Point: $232,535 $59,974 $0 $899,600 $0 $599,720 Facility Facility A Bonus / (Penalty) $97,593 Total Score 42.03 State Average 41.81933117 National Average 41.70169535 National Δ 0.325577377 Measure Score Amount Earned by Measure Amount Unearned by Measure % of Measure Earned Core Measures AMI-8a SCIP-Inf-1 SCIP-Inf-2 SCIP-Inf-3 SCIP-Inf-4 SCIP-Inf-9 HF-1 PN-3b PN-6 SCIP-Card-2 SCIP-VTE-2 Core Measures TOTAL 6 9 7 5 9 5 8 5 8 3 5 $ $ $ $ $ $ $ $ $ $ $ $ 32,712 49,068 38,164 27,260 49,068 27,260 43,616 27,260 43,616 16,356 27,260 381,643 $ $ $ $ $ $ $ $ $ $ $ $ 21,808 5,452 16,356 27,260 5,452 27,260 10,904 27,260 10,904 38,164 27,260 218,077 60.00% 90.00% 70.00% 50.00% 90.00% 50.00% 80.00% 50.00% 80.00% 30.00% 50.00% 63.64% Comm. w/ Nurses Comm. w/ Doctors Resp. of Hosp. Staff Pain Management Comm. Re: Medicines Clealiness & Quietness Discharge Information Overall Rating 2 1 2 2 1 2 3 1 $ $ $ $ $ $ $ $ 17,994 8,998 17,994 17,994 8,998 17,994 26,990 8,998 $ $ $ $ $ $ $ $ 71,966 80,962 71,966 71,966 80,962 71,966 62,970 80,962 20.00% 10.00% 20.00% 20.00% 10.00% 20.00% 30.00% 10.00% Consistency Score HCAHPS TOTAL 17 $ $ 152,933 278,896 $ $ 26,987 620,704 85.00% 31.00% AMI HF PN AHRQ PSI-90 CLABSI Outcomes TOTAL 10 3 8 9 0 $ $ $ $ $ $ 179,920 53,980 143,934 161,928 0 539,763 $ $ $ $ $ $ (0) 125,940 35,986 17,992 179,920 359,837 100.00% 30.00% 80.00% 90.00% 0.00% 60.00% MSPB 1 $ $ 59,974 59,974 $ $ 539,746 539,746 10.00% Efficiency TOTAL Facility TOTAL $ 1,260,277 $ 1,738,363 42.03% HCAHPS Outcomes Efficiency Pain Management Comm. Re: Medicines Clealiness & Quietness Discharge Information Overall Rating 2 1 2 3 1 $ $ $ $ $ 17,994 8,998 17,994 26,990 8,998 $ $ $ $ $ 71,966 80,962 71,966 62,970 80,962 20.00% 10.00% 20.00% 30.00% 10.00% Consistency Score HCAHPS TOTAL 17 $ $ 152,933 278,896 $ $ 26,987 620,704 85.00% 31.00% AMI HF PN AHRQ PSI-90 CLABSI Outcomes TOTAL 10 3 8 9 0 $ $ $ $ $ $ 179,920 53,980 143,934 161,928 0 539,763 $ $ $ $ $ $ (0) 125,940 35,986 17,992 179,920 359,837 100.00% 30.00% 80.00% 90.00% 0.00% 60.00% MSPB 1 $ $ 59,974 59,974 $ $ 539,746 539,746 10.00% 1,738,363 42.03% Drilldown on Outcomes… Outcomes Efficiency Efficiency TOTAL Variation within the Domain: Facility TOTAL $ 1,260,277 $ Maxed out on AMI Mortality and then got a 0 on CLABSI Opportunities – VBP: Outcomes 1 30 Day Mortality Rate - PN ∆ FY14 87.40% Performance -2.18% 89.58% Baseline -0.78% 88.18% Threshold -2.81% 90.21% Benchmark 0 Score Improvement +1% +1.5% +2.5% +3.5% +4.5% +5.5% +6.5% +7.5% +8.5% Dollar Value 13,209 $ 52,836 $ 105,673 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ Score 1 4 8 10 10 10 10 10 10 2 30 Day Mortality Rate - AMI ∆ FY14 83.81% Performance -0.95% 84.76% Baseline -0.96% 84.77% Threshold -2.92% 86.73% Benchmark 0 Score Improvement +1% +1.5% +2.5% +3.5% +4.5% +5.5% +6.5% +7.5% +8.5% Dollar Value 13,209 $ 39,627 $ 105,673 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ Score 1 3 8 10 10 10 10 10 10 3 30 Day Mortality Rate - HF ∆ FY14 85.21% Performance -3.73% 88.94% Baseline -3.40% 88.61% Threshold -5.21% 90.42% Benchmark 0 Score Improvement +1% +1.5% +2.5% +3.5% +4.5% +5.5% +6.5% +7.5% +8.5% Dollar Value $ $ $ 13,209 $ 79,254 $ 132,091 $ 132,091 $ 132,091 $ 132,091 $ Score 0 0 0 1 6 10 10 10 10 Top 50th = Δ1 Patient Top 50th = Δ1 Patient Top 50th = Δ8 Patients Top 10th = Δ3 Patient Top 10th = Δ3 Patient Top 10th = Δ11 Patients 42 VBP – CMS Proposed Future Measures • FY 2018 Program (Performance Period: CY 2016) – Patient Experience: Care Transition • FY 2019 Program (Performance Period: CY 2017) – Surgical Complication: Total Hip and Total Knee Arthroplasty FY 19 New Measure • Added THA/TKA for 30 month performance period. – January 1, 2015-June 30, 2017 – Baseline of July 1, 2010-June 30, 2013 • Risk standardized measure for complications after Total Hips and Knees surgeries for up to 90 days post surgery – One of eight complications: AMI, pneumonia, sepsis, SSI, PE, death, mechanical complication or periprosthetic joint infection/wound infection. – Each has a defined time frame – Each is a ‘Yes’ or ‘No – Risk adjusted for patient age, sex and comorbidities SOURCE: August 2014 Proposed Rules Federal Register 44 Readmission Reduction Program Reform Timeline • Readmission Reduction Program 9% of Current and Future Medicare Reimbursement at Risk – 3% penalty of Medicare Reimbursement at risk each program year – Measured Populations 30 days from DISCHARGE • AMI, HF, PN, COPD, THA & TKA • August 2014: CABG Added to FY 2017 • Performance Periods: 3 Year Rolling Program – FY’15: July 1, 2010 – June 30, 2013 – 3% – FY’16: July 1, 2011 – June 30, 2014 – 3% – FY’17: July 1, 2012 – June 30, 2015 – 3% – FY’18: July 1, 2013 – June 30, 2016 – 3% – FY’19: July 1, 2014 – June 30, 2017 – 3% Currently participating in 3 performance periods simultaneously How are Readmissions Measured? • Scoring Index based at 1.0 • Calculate Excess Readmission Ratio Facility Predicted Value Facility Expected Value • Excess Readmission Ratio > 1 = BAD • Excess Readmission Ratio < 1 = GOOD Wisconsin RRP By Facility: FY 13- FY 15 RRP % 1.80% 1.60% 1.40% 1.20% 1.00% 0.80% 0.60% 0.40% 0.20% 0.00% FY 13 FY 14 FY 15 Hospital Acquired Conditions Reform Timeline Hospital Acquired Conditions (1% at Risk*) • 12 Hospital Acquired Conditions Identified – Divided in to 2 Domains • If a hospital is in the BOTTOM QUARTILE (worst performing 25% in the country), it will be penalized a FULL 1% of Medicare Reimbursement • Penalties will begin FY’15 (beginning October 1, 2014) *1% After DSH, Uncompensated Care, and IME Penalties & Your DRG Payment SAMPL IPPS Reimbursement Letter PPS EFFECTIVE 10/1/2014 OPERATING INFORMATION Federal National Standardized Labor Rate Wage Index Labor Rate x Wage Index Federal National Standardized Non-Labor Rate PPS Blended Rate FY 2015 Hospital Readmissions Reduction (HRR) Adjustment Factor FY 2015 Value-Based Purchasing (VBP) Adjustment Factor DRG Weight Facility CMI 0.9994 0.994348 1.00 1.54 3,329.57 0.8994 2,994.62 2,040.71 5,035.33 5,032.30 5,003.86 ($3.02) RRP Reduction ($28.44) VBP Reduction ($31.46) Per DRG Reduction ($31.46) x 1.54 Disproportionate Share Adjustment (Operating) (Empirically Justified Amount 25%) Disproportionate Share Adjustment (Operating) (Uncompensated Care Amount) Fully Loaded Operating Rate adjusted for CMI FY 2015 Hospital Acquired Condition (HAC) Adjustment Factor 0.0691 0.99 ($48.45) VBP & RRP Per DRG Red. CMI Adj ($83.47) HAC Per DRG CMI Adjusted ($131.92) Total Per DRG Reduction 0.02 5,090.43 507.71 5,598.14 8,346.97 8,263.50 Hospital Acquired Conditions: FY’15 First Domain: PSIs Performance Period: 7/1/11-6/30/13 Second Domain: CDC Performance Period: CY 2012 & 2013 Pressure Ulcer Rate CLABSI Foreign Object Left in Body CAUTI Iatrogenic Pneumothorax Rate Postoperative Physiologic and Metabolic Derangement Rate Postoperative Pulmonary Embolism and Deep Vein Thrombosis Rate Accidental Puncture and Laceration Rate HAC Domain Weightings: FY’15 DOMAIN 1: 35% Pressure Ulcer Rate: 8.33% DOMAIN 2: 65% CLABSI: 32.5% Foreign Object Left In Body: 8.33% CAUTI: 32.5% Hospital Acquired Conditions: FY 2016 First Domain: PSIs 25% Second Domain: CDC 75% Pressure Ulcer Rate CLABSI Foreign Object Left in Body CAUTI Iatrogenic Pneumothorax Rate SSI Following Colon Surgery (FY 2016) Postoperative Physiologic and Metabolic Derangement Rate SSI Following Abdominal Hysterectomy (FY 2016) Postoperative Pulmonary Embolism and Deep Vein Thrombosis Rate Accidental Puncture and Laceration Rate HAC Domain Weightings: FY’16 DOMAIN 1: 25% DOMAIN 2: 75% Pressure Ulcer Rate: 5.83% CLABSI: 32.5% SSI: 32.5% CAUTI: 32.5% 57 Hospital Acquired Conditions: FY 2017 First Domain: PSIs Second Domain: CDC Pressure Ulcer Rate CLABSI Foreign Object Left in Body CAUTI Iatrogenic Pneumothorax Rate SSI Following Colon Surgery (FY 2016) Postoperative Physiologic and Metabolic Derangement Rate SSI Following Abdominal Hysterectomy (FY 2016) Postoperative Pulmonary Embolism and Methicillin-Resistant Staphylococcus Deep Vein Thrombosis Rate Aureus (MRSA) Bacteremia (FY 2017) Accidental Puncture and Laceration Rate Clostridium Difficile (FY 2017) Dollars At Risk VBP FY 2016 – Sample Current $$ at Risk VBP FY 2016 Domain Weight At Risk Medicare Spend Per Beneficiary 25% $ 745,471 Outcomes 40% $ 1,192,753 Patient Experience 25% $ 745,471 Core Measures 10% $ 298,188 TOTAL 100% On the Table $ 1,562,507 $ 2,500,011 $ 1,562,507 $ 625,003 $ 2,981,883 $ 6,250,028 VBP – Sample Total Current $$ at Risk VBP Current Dollars At Risk (Active Performance Periods) On the Table At Risk Weight Domain FY 2016 1,562,507 $ 745,471 $ 25% Medicare Spend Per Beneficiary 2,500,011 $ 1,192,753 $ 40% Outcomes 1,562,507 $ 745,471 $ 25% Patient Experience 625,003 $ 298,188 $ 10% Core Measures FY 2017 1,785,722 $ 851,967 $ 25% Outcomes - 30 Day Mortality 267,858 3.75% $ 127,795 $ Outcomes - AHRQ FY 2018** 1,785,722 $ 851,967 $ 25% Outcomes - 30 Day Mortality 267,858 3.75% $ 127,795 $ Outcomes - AHRQ FY 2019** 1,785,722 $ 851,967 $ 25% Outcomes - 30 Day Mortality TOTAL $ 5,793,374 $ 12,142,911 All Reform – Sample Total Current $$ at Risk All Active Mandatory Reform Domain On the Table FY 2016 Value Based Purchasing Readmissions Hospital Acquired Conditions FY 2017 Value Based Purchasing Readmissions Hospital Acquired Conditions FY 2018** Value Based Purchasing Readmissions FY 2019** Value Based Purchasing** Readmissions TOTAL $ 6,250,028 COMPLETE $ 1,703,933 $ $ $ 2,053,581 5,111,800 1,703,933 $ $ 2,053,581 5,111,800 $ $ 1,785,722 5,111,800 $ 30,886,178 VBP – CMS Proposed Future Measures • FY 2018 Program (Performance Period: CY 2016) – Patient Experience: Care Transition • FY 2019 Program (Performance Period: CY 2017) – Surgical Complication: Total Hip and Total Knee Arthroplasty FY 19 New Measure • • Added THA/TKA for 30 month performance period. – January 1, 2015-June 30, 2017 – Baseline of July 1, 2010-June 30, 2013 Risk standardized measure for complications after Total Hips and Knees surgeries for up to 90 days post surgery – One of eight complications: AMI, pneumonia, sepsis, SSI, PE, death, mechanical complication or periprosthetic joint infection/wound infection. – Each has a defined time frame – Each is a ‘Yes’ or ‘No – Risk adjusted for patient age, sex and comorbidities SOURCE: August 2014 Proposed Rules Federal Register 64 Bundled Payments Description of Models 1 - 4 Models 2 and 3 are the most popular by farretrospective vs prospective models that include the post acute care components 66 Bundled Payments Model 1 and 4 Model 1 is Retrospective and is all DRGs Model 4 is Prospective Acute Readmission Home LTACH/SNF/ IRF HH 67 Bundled Payments Model 2 Model 2 is Retrospective For 30-60-90 days Acute Readmission Home LTACH/SNF/ IRF HH 68 Bundled Payments Model 3 Model 3 is Retrospective For 30-60-90 days Acute Readmission Home LTACH/SNF/ IRF HH 69 The Episodes • CMS created 48 Episodes, each with up to 15 individual MS-DRG codes • We categorized Episodes into 9 Service Lines; illustrative purposes only • Model 2, 3, or 4 applicants may select 1-48 Episodes for testing Spine (5) Cardiac Services (12) Vascular Services (3) Orthopedics (10) Neurology (2) Oncology / Hematology (1) General Surgery (2) General Medicine / Internal Medicine (10) Pulmonology (3) http://innovation.cms.gov/initiati ves/bundled-payments/ 70 Advantages of Participation • Improved quality of care for patients – Reduced complications, readmissions, and cost • Improved ability to work with hospitals, physicians, nursing homes, home health, rehab centers, and other providers to improve overall care quality and service • Potential competitive advantage within market with physicians and post-acute care • Opportunity to receive payment aligned with these goals and based on outcomes 71 Where are the Bundled Payments? MEDICARE: Cohort 1 COMMERCIAL as of July 2014 http://innovation.cms.gov/initiatives/bundled-payments/ 72 Early Results of BPCI Cohort 2 • Tremendous increase in the number of applications in the most recent open enrollment in April 2014: Nearly Triple! • Models 2,3,4 were open for enrollment • Currently in the Phase 1 period which is the non risk, decision making period. Phase 2 is when the Episode Initiator starts to accept risk Changes In the Cohort 2 Timeline: 7/31/14 Event Original Date Revised Date* Historical Claims & Target Pricing Late Summer 2014 November 2014 Go/No Go Decision November 1, 2014 to Participate January 11, 2015 Go Live with Risk April 1, 2015 January 1, 2015 Other significant changes: ADDITION OF EPISODES: You can now add episodes in July 2015 and October 2015: only 1 episode is required for April 1, 2015. Phase 1 ends in October 2015 B-CARE: B-CARE quality data wont be collected until Spring 2015 Option for Delayed Reconciliation: Will offer a 4 quarter timeline for reconciliation. * Revised again in October 2014 Readiness: Risk Capability • What are your data analytics and capabilities and ability to operationalize your quality data • What is the maturity of your physician network and post acute care network? What do you know about each? What don’t you know? • How are you doing on the VBP and RRP that are building blocks for this? How are you going to manage the gain sharing • What quality metrics are you tracking and need to improve that can be built into this program • What internal cost sharing could you roll out with 75 this? Strategic Planning: How does it all tie in? System/Facility Strategic Plan Clinically Integrated Networks/Post Acute Care Networks Payment Models MSSP/BPCI/VBP/RRP/HAC Managed Care/Direct to Employer Opportunities 76 DRG 470 Total Joint Replacement w/out CC Model 2 $3,207 MD + DRG Inpatient and PACS Fee for Service Model + + $10,12 $8,965 $616 9 • • • • Home Health SNF IRF Outpt. Rehab = $22,927 x 98% Home $22,468 Readmission Episodic period for model 2: 3 days prior to admission to 90 days post discharge from hospital $22,468 Bundled Episodic Model Note: any CMI aggregate charges lower than $22,468 can be shared with providers via gain sharing model Gain Sharing Model Shared Reward ($$) Physician Setting Surgeon Hospital Anesthesiologist SNF Hospitalist Home Health Outpatient Physician 78 Bundled Payment Episode Pricing and Gain Sharing 2008-2009 Historical Cost Per Episode $12,500 2013 Update factor Target Price $13,647 Quality Metrics For illustration: 3% inflation/yr Discount = 3% Settlement (Per Case) $247 BPLN Episode Definitions Risk Adjustment Physicians (35%) $86 Actual FFS Cost during Performance Period $13,400 Quality Metrics Quality Metrics Environment of Care - Hospital (40%) $99 Environment of Care - Post-acute (25%) $62 79 BPCI Multiple Bonus Payments: Physicians • 2 opportunities for Physicians to be awarded Bonuses 1. Internal Cost Savings Pool 2. Bundled Payment Savings Pool • Both have required Quality Metrics and Cost Savings to be met • Cost Savings MUST be directly attributed to Quality Improvement and Care Redesign 80 Outpatient Bundling…coming soon? In February 2014, CMMI issued a Request for Information on a new bundled payment program to expand to outpatient. • • • Focus is Specialty Physicians and on (1) Procedures and (2) complex chronic care Highlighted colonoscopy, cataract surgery, & radiation therapy for procedural options. Regarding the chronic care, “CMS is considering development of a model that would incentivize specialists to more efficiently manage the care provided to beneficiaries with complex or chronic medical conditions over the period of time that corresponds to the specialty practitioner’s long term involvement with managing the beneficiary’s care.” Was seeking responses until March 13 • Outpatient Bundling Referred to by CMS as: “Comprehensive Ambulatory Payment Classification (APC)” • Finalized in the CY 2014 OPPS/ASC Final Rule • Affect payments to 4,000 hospitals and 5,300 ASC’s • Delayed implementation to January 1, 2015 instead of the traditional outpatient October 1 implementation date – Extra time allowed the Agency, hospitals, and physicians more time to evaluate and comment on the policy Outpatient Bundling – Comprehensive APC’s • Single Medicare payment rather than individual APC payments throughout the episode • 25 Bundled Outpatient Procedures • Proposed Payment could include all hospital services reported on the claim covered under Medicare Part B for up to a proposed 6 Month Period – Few exceptions resulting in a single beneficiary copayment per claim Outpatient Bundling – Proposed Procedures No. Clinical Family Proposed CY 2015 APC 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 AICDP AICDP AICDP AICDP AICDP BREAS CATHX CATHX ENTXX EPHYS EPHYS EPHYS EYEXX EYEXX GIXXX NSTIM NSTIM NSTIM ORTHO PUMPS RADTX UROGN UROGN UROGN VASCX VASCX VASCX VASCX 0090 0089 0655 0107 0108 0648 0427 0652 0259 0084 0085 0086 0293 0351 0384 0061 0039 0318 0425 0227 0067 0202 0385 0386 0083 0229 0319 0622 APC Title Level II Pacemaker and Similar Procedures Level III Pacemaker and Similar Procedures Level IV Pacemaker and Similar Procedures Level I ICD and Similar Procedures Level II ICD and Similar Procedures Level IV Breast and Skin Surgery Level II Tube or Catheter Changes or Repositioning Insertion of Intraperitoneal and Pleural Catheters Level VII ENT Procedures Level I Eletrophysiologic Procedures Level II Eletrophysiologic Procedures Level III Eletrophysiologic Procedures Level IV Intraocular Procedures Level V Intraocular Procedures GI Procedures with Stents Level II Neurostimulator & Related Procedures Level III Neurostimulator & Related Procedures Level IV Neurostimulator & Related Procedures Level V Musculoskeletal Procedures Except Hand and Foot Implantation of Drug Infusion Device Single Session Cranial Stereotactic Radiosurgery Level V Female Reproductive Procedures Level I Urogenital Procedures Level II Urogenital Procedures Level I Endovascular Procedures Level II Endovascular Procedures Level III Endovascular Procedures Level II Vascular Access Procedures Proposed CY 2015 APC Geometric Mean Cost $ 6,961.45 $ 9,923.94 $ 17,313.08 $ 24,167.80 $ 32,085.90 $ 7,674.20 $ 1,522.15 $ 2,764.85 $ 31,273.34 $ 922.84 $ 4,807.69 $ 14,835.04 $ 9,049.66 $ 21,056.40 $ 3,307.90 $ 5,582.10 $ 17,697.46 $ 27,283.10 $ 10,846.49 $ 16,419.95 $ 10,227.12 $ 4,571.06 $ 8,019.38 $ 14,549.04 $ 4,537.95 $ 9,997.53 $ 15,452.77 $ 2,635.35 Thank you! Contact Information: Melinda Hancock Melinda.Hancock@dhgllp.com (804) 474-1249 Affinity Groups • Current • Newly Formed and Actively Meeting – Large System CFO Council – Health Care Economics Professional Council – Large System Revenue Cycle Council – Physician Group Practice Executive Council – Strategic CFO Council • Being Formed – Strategy Executive Council – CMMI Bundled for Care Improvement Council – Academic Medical Center CFO Council – Payer Focused Affinity Group 86 Master Level Seminars • • • Chicago, IL | Dec. 8-10, 2014 – Beyond Big Data: Developing a Business Intelligence and Analytics Practice – Population Health Management and the Next Generation of Clinical Integration Washington, DC | Feb. 18-20, 2015 – Population Health Management and the Next Generation of Clinical Integration – Transparency, Metrics, and Communication: Proven Practices for Revenue Cycle Strategies Seattle, WA | March 25-27, 2015 – Beyond Big Data: Developing a Business Intelligence and Analytics Practice – Transparency, Metrics, and Communication: Proven Practices for Revenue Cycle Strategies 87 Improve the Billing and Payment Experience for Patients hfma.org/dollars 88 Price Transparency Task Force 89 Enhance Price Transparency • Clarifies basic definitions that are often misused • Sets forth guiding principles • Establishes roles for payers, providers, others • Reflects consensus of key stakeholders hfma.org/dollars 90 Demystify Price Information for Consumers • Describes how to request price estimates, step by step • Clarifies what estimates may or may not include • Explains in-network and out-of-network care • Defines key terms • Available for posting on your website at no charge • Hardcopies available for purchase in bulk at a nominal price through AHA’s online store hfma.org/transparency ahaonlinestore.org 91 Best Practices Address Key Issues Provision of Care Registration and Insurance Verification Financial Counseling Patient Share Prior Balances (if applicable) Balance Resolution 92 Achieve Recognition as an Adopter of Best Practices • Recognition demonstrates commitment to best practices in patient financial communications • Based on HFMA review of an application and supporting documentation • All provider organizations may apply • Recognition valid for two years • Adopters may use the phrase “Supporter of the Patient Financial Communications Best Practices” in their marketing materials 93 Leading the Change from Volume to Value • Defining and delivering value • Key organizational capabilities for building value • Organizational road maps hfma.org/valueproject 94 New Report Extends Value Resources to Reflect Industry Realignment Current State & Future Directions of Value Acquisition and Affiliation Strategies Defining & Delivering Value HMFA’s Value Project HMFA’s Value Project Value In Health Care Defining and Delivering Value Acquisition and Affiliation Strategies HMFA’s Value Project HMFA’s Value Project Building ValueDriving Capabilities Four Key Capabilities for Value hfma.org/valueproject The Value Journey: Organizational Road Maps for Value Driven Health Care Organizational Road Maps for Value-Driven Health Care Career Strategies HFMA Resources “Choose a job you love, and you will never have to work a day in your life.” Confucius 96 Take Advantage of HFMA Resources 97 Leadership… Your personal plan…what does it really mean? “Leadership has nothing to do with titles; it has everything to do with, “Do you inspire other people? Do they want to follow you? Do they want to be with you?” -Tom Atchison, author of Followership: A Practical Guide to Aligning Leaders and Followers 98 Be an Exceptional Leader • Well cultivated self awareness • Compelling vision • A real way with people • Masterful execution 99 Be “Great by Choice” • 10ers are extremely disciplined – They use empirical data and continually plan for the “what if” • The take the 20 Mile March – Performance markers and self imposed constraints • Fire bullets instead of cannonballs. – Only shoot cannon balls after testing. • Show great financial constraint • Zoom out – then zoom in. 100 Develop Your Leaders… “You cannot lead without knowing the needs of your people—what drives them, what makes them do what they do; then you can give them opportunities to succeed based on their own psychology of success.” Kerry Gillespie, FHFMA, vice president, operations, Community Health System, Inc., Brentwood, TN, and a member of HFMA’s Tennessee Chapter 101 101 Everyone Is a Leader…. Everyone in this room is a leader. I’m asking each of you to renew your commitment to leading our industry forward, to ensuring its long term viability and quality. Together, we CAN improve health care. Together, we can and we must • Mentor young professionals as we have been mentored, • Rise above the uncertainty and frustration of today, and • Work in partnership with our colleagues throughout the industry to lead the change. Kari Cornicelli HFMA National Chair 2014/2015 102 New Skills for A Leader • Convening collaborative efforts • Making decisions on behalf of your organization • Commitment to move the alliance forward • Confidence that the alliance will "get to its destination" 103 Trend Toward Collaboration Across Traditional Boundaries 8 Key Elements Required for Successful Collaboration 1. A common pain (a shared problem) 2. A convener of stature (an influential leader) 3. Representatives of substance with authority to make decisions 4. Leaders committed to move the alliance forward 5. A clearly defined purpose 6. Established rules 7. Confidence that the alliance will "get to its destination" 8. A shared pool of reliable information 104 Source: 2013. Mike Leavitt and Rich McKeown. Finding Allies, Building Alliances: 8 Elements That Bring…and Keep People Together Leading Change- Summary 105